Obesity in heart failure with preserved ejection fraction with and without diabetes: risk factor or innocent bystander?
Open Access
- 21 May 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 30 (12) , 1247-1254
Abstract
Aims: Heart failure with preserved ejection fraction (HFpEF) is a condition that commonly coexists with type 2 diabetes mellitus (T2DM) and obesity. Whether the obesity-related survival benefit generally observed in HFpEF extends to individuals with concomitant T2DM is unclear. This study sought to examine the prognostic role of overweight and obesity in a large cohort of HFpEF with and without T2DM. Methods and results: This large-scale cohort study included patients with HFpEF enrolled between 2010 and 2020. The relationship between body mass index (BMI), T2DM, and survival was assessed. A total of 6744 individuals with HFpEF were included, of which 1702 (25%) had T2DM. Patients with T2DM had higher BMI values (29.4 kg/m2 vs. 27.1 kg/m2, P < 0.001), higher N-terminal pro-brain natriuretic peptide values (864 mg/dL vs. 724 mg/dL, P < 0.001), and a higher prevalence of numerous risk factors/comorbidities than those without T2DM. During a median follow-up time of 47 months (Q1–Q3: 20–80), 2014 (30%) patients died. Patients with T2DM had a higher incidence of fatal events compared with those without T2DM, with a mortality rate of 39.2% and 26.7%, respectively (P < 0.001). In the overall cohort, using the BMI category 22.5–24.9 kg/m2 as the reference group, the unadjusted hazard ratio (HR) for all-cause death was increased in patients with BMI <22.5 kg/m2 [HR: 1.27 (confidence interval 1.09–1.48), P = 0.003] and decreased in BMI categories ≥25 kg/m2. After multivariate adjustment, BMI remained significantly inversely associated with survival in non-T2DM, whereas survival was unaltered at a wide range of BMI in patients with T2DM. Conclusion: Among the various phenotypes of HFpEF, the T2DM phenotype is specifically associated with a greater disease burden. Higher BMI is linked to improved survival in HFpEF overall, while this effect neutralises in patients with concomitant T2DM. Advising BMI–based weight targets and weight loss may be pursued with different intensity in the management of HFpEF, particularly in the presence of T2DM.Keywords
Funding Information
- Austrian Science Fund (KLI 700-B30)
This publication has 36 references indexed in Scilit:
- Exercise Training Improves Exercise Capacity and Diastolic Function in Patients With Heart Failure With Preserved Ejection FractionJACC, 2011
- Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection FractionCirculation: Heart Failure, 2011
- State of the union between metabolism and the immune system in type 2 diabetesGenes & Immunity, 2011
- Absence of Obesity Paradox in Patients with Chronic Heart Failure and Diabetes Mellitus: A Propensity-Matched StudyEuropean Journal of Heart Failure, 2011
- Exercise Training in Older Patients With Heart Failure and Preserved Ejection FractionCirculation: Heart Failure, 2010
- Comparison of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction Among Those With Versus Without Diabetes MellitusThe American Journal of Cardiology, 2010
- Adipose tissue distribution is different in type 2 diabetesThe American Journal of Clinical Nutrition, 2009
- Irbesartan in Patients with Heart Failure and Preserved Ejection FractionNew England Journal of Medicine, 2008
- Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programmeEuropean Heart Journal, 2008
- Body Mass Index and Prognosis in Patients With Chronic Heart FailureCirculation, 2007